RNTX

0.33698.38%
CM

Cory M. Hogaboam

Chief Scientific Officer

Dr. Cory M. Hogaboam, Ph.D., is Chief Scientific Officer of Rein Therapeutics Inc. (formerly known as Aileron Therapeutics, Inc.) Dr. Hogaboam serves as Member of Advisory Board at Lassen Therapeutics 1, Inc. Dr. Hogaboam serves as Member of Scientific Advisory Board at Rubedo Life Sciences, Inc since June 2021. He serves as Chief Scientific Officer at Lung Therapeutics, Inc. since April 2021. Previously, Dr. Hogaboam served on Lung Therapeutics? Medical Advisory Board. Dr. Hogaboam?s distinguished career encompasses scientific experience. He is a Professor of Medicine and Research Scientist in the Women?s Guild Lung Institute at Cedars Sinai Medical Center and an Adjunct Professor of Pathology at the University of Michigan Medical School. Dr. Hogaboam is on the editorial board of the American Journal of Respiratory and Critical Care Medicine and the Journal of Clinical Investigation Insight. He has authored or co-authored 11 patents on therapeutic interventions for lung and liver. Dr. Hogaboam has received financial research support from the National Institutes of Health, American Lung Association, Canadian Institutes of Health Research and several Industry sponsors. He earned a bachelor?s of science in zoology from the University of Calgary and holds a doctorate?s degree in Pharmacology from the same institution. Dr. Hogaboam completed postdoctoral training in Immunology at McMaster University and Pathology at the University of Michigan.

Positions